9th Dec 2009 09:28
9 December 2009
Oxeco plc
Investing policy update
The Company would like to clarify its investing policy in line with revised AIM Rules for investing companies.
The company's investing policy is as follows:
To invest in companies or projects in the science and technology sectors
To invest through limited liability vehicles including company acquisitions, joint ventures and minority holdings, or where appropriate through the purchase of pure intellectual property
Any such acquisition may be deemed a reverse takeover as per AIM Rule 14
The investment may be passive or active which will be driven by the size of the stake and the Company would like to retain the flexibility to assess this on a case by case basis
The company will not be seeking to define any length of time for any investment nor any target returns at this stage
Update
The Board are continuing to review appropriate targets in the science and technology sectors, however, no specific target has progressed beyond due diligence to date. The Company has £ 2.3 million for the purposes of the investing strategy as defined in the above investing policy.
For further information, please contact:
|
Michael Bretherton Oxeco plc www.oxecoplc.com |
+44 (0) 20 7099 7266 |
|
Ray Zimmerman/Jonathan Evans ZAI Corporate Finance Ltd. |
+44 (0) 20 7060 1760 |
Related Shares:
Tissue Regenix Group